Aptamer: A New Class of Oligonucleotide for Therapeutic and Diagnostic Use - Review

Authors

  • Dr. Shilpa P
  • Priyanka Udhdavrao Shinde Shinde
  • Dr. Shilpa P. Chaudhari Chaudhari

DOI:

https://doi.org/10.46243/jst.2020.v5.i3.pp19-24

Keywords:

Aptamer, DNA, RNA, Peptide, Antibody, Generation, Application

Abstract

Recently, aptamers get the attention of many scientist, because they have all advantages of antibodies which found in human body. They also have unique merits like thermal stability, low cost, and many more. Aptamers are the short sequence nucleic acid with a high affinity and specificity. It is globally adopted as a one of the advance and promising drug delivery technique. These aptamers are produced by in vitro selection method using SELEX technique. This review contains the discussion on the aspect of design, unique properties, applications of aptamers to aid in cancer diagnosis, prevention and treatment under fine condition. Finally, several medical and analytical applications are presented.

References

Zhang,Y.,et.al. Tumor-Targeted Drug Delivery with Aptamers. Curr. Med. Chem.2011. 18(27): 4185-94

Sun,H.et al. Oligonucleotide Aptamers: New Tools for Targeted Cancer Therapy. Molecular Therapy Nucleic Acids. 2014.3, e182. Doi: 10.1038/mtna.2014.32

Jayasena, S.D. Apatmers: An emerging class of molecules that rival antibodies in diagnostics. Clinical Chemistry.1999.45(9): 1628-50

Vinkenborg, J.L.,et al. Aptamers for allosteric regulations. Nature Chemical Biology. August 2011.7;519-27

Xu, Li, et al. Cellular Internalization and Cytotoxicity of Aptamers Selected from Lung Cancer cell. American Journal of Biomedical Sciences. 24 December 2012

Kabori, S.et al. Kinetic analysis of aptazyme-regulated gene expression in a cell- free translation system: Modeling of liganddependant and-independent expression. RNA.2012.18(8): 1458-65

A.V. Lakhin, V.Z. Taranful, Aptamers: Problems, Solution and Prospects, Acta Naturae. 2013 Oct-Dec; 5(4): 34–43

Colas P, Cohen B, “Genetic selection of peptide aptamers that recognize and inhibit cyclin-dependant kinase 2” Nature 380(6574):548-50

Mohamad H. Ali, Marwa E. Elsherbiny, Review update on aptamer research. Int. J. Mol. Sci. 2019, 20,2511

Yang Zhang,BoShiun Lai, Review on Recent Advances in Aptamer Discovery and Application, Molecules 2019,24

ZhenjjanZhuo, Yuanyanyu, Recent Advances in SELEX Technology and Aptamer Application in Biomedicine, Int. J. Mol.Sci, 2017, 18 (10):2142

Tatjana Schutze, Barbara Wilhelm, Probing the SELEX Process with Next–Generation Sequencing,Journal pone,2011

Baby Santosh, Promad, K, Yadava, Review article on Nucleic Acid Aptamers: Research Tool in Disease Diagnostic and Therapeutics, BioMed Research International Volume 2014

D. J. Stickle,J.B. King, Blockage of uretheral catheters by bacterial biofilms, Journal of Infection,1993, Vol.27,no.2, P.NO. 133-

W. C. Winkler, R. R. Breaker, “ Regulation of bacterial gene expression by riboswitches, Annual Review of Microbiology, 2005, vol.29, P.No- 487-517

Kyung Mi-Song,Seonghwan Lee, “Aptamer and Their Biological Application,’’ Sensors 2012, 12, 612-631

B. J. Tucker and R.R. Breaker, Riboswitches as versatile gene control element, Current Opinion in Structural Biology,2005, vol. 15, no.3, P.No. 342-348.expected places, Wiley Inter

K. Matyalla-Kulinska, J.L. Boots, Finding aptamers and small ribozymes in unexpected place, Wiley Interdisciplinary Review : RNA, 2012, vol.3, no.1, P.No.73-91

Y.Wan, Y.Kim, N.et al., “Surface-immobilized aptamers for cancer cell isolation and microscopic cytology’’ Cancer Research, 2010,vol.70,no.22, P.No-9371-9380

P.Zhang, N. Zhao, “ Using an RNA Aptamer probe for flow cytometry detection of CD30 expressing lymphoma cells’’ Laboratory Investigation,2009,vol.89,no.12, P.No-1423-1432

D.H.J. Bunka, P.G. Stockley, “Aptamers come of age-at last’’ Nature Reviews Microbiology, 2006,vol.4, no.8, P.No-588-596

T.G. McCauley, N. Hamaguchi, “Aptamer based biosensor arrays for detection and quantification of biological macromolecules’’, Analytical Biochemistry, 2003,vol.319, no.2,P.No- 244-250

S. Sivanesan, M.D. Howell,” Antisense oligonucleotide mediate therapy of spinal muscular atropy,’’ Translational Neuroscience,2013,vol.4, no.1, P.No-1-7

Published

2020-04-28

How to Cite

Dr. Shilpa P, Shinde, P. U. S., & Chaudhari, D. S. P. C. (2020). Aptamer: A New Class of Oligonucleotide for Therapeutic and Diagnostic Use - Review. Journal of Science & Technology , 5(3), 19–24. https://doi.org/10.46243/jst.2020.v5.i3.pp19-24